Outcome analysis of percutaneous nephrostomy insertion to relieve urinary obstruction in advanced malignancy
Urology Annals · 2025-10 · 17 (4) · 239-244
DOI: 10.4103/ua.ua_74_25 ↗Abstract
Objective: The aim is to evaluate the benefits of percutaneous nephrostomy (PCN) for urinary drainage in patients with malignancy-associated urinary obstruction (MUO). This study examines the impact of PCN on immediate renal recovery, procedural morbidity, short-term outcomes, and patient survival. Methods: A total of 477 patients with ureteric obstruction underwent PCN placement, of whom one-third had MUO. Demographic and clinical parameters were reviewed to assess renal outcomes, complication rates, hospital stay, and overall survival. Results: Nearly two-thirds of the patients with MUO had a primary urological malignancy (bladder cancer 30% and prostate cancer 25%). The mean hospital stay was
EUVIMED